Table 3.
Comparison of semen parameters in HPV-positive semen samples.
| HPV DNA+ (n = 38) n (%) |
HPV DNA− (n = 191) n (%) |
p | HR HPV+ (n = 13) n (%) |
HR PV− (n = 216) n (%) |
p | LR HPV+ (n = 14) n (%) |
LR HPV− (n = 215) n (%) |
p | HPV MI+ (n = 14) n (%) |
HPV MI− (n = 215) n (%) |
p | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hypospermia | 6 (15.8) | 15 (7.8) | 0.2 | 4 (25) | 17 (8) | 0.3 | 0 (0) | 21 (9.7) | 0.6 | 5 (35.7) | 16 (7.44) | 0.01 |
| Abnormal coagulation time | 0 (0) | 5 (2.6) | 1 | 1 (8.3) | 2 (0.9) | 0.1 | 0 (0) | 5 (2.3) | 1 | 0 (0) | 5 (2.3) | 1 |
| Abnormal viscosity | 17 (44.7) | 23 (12.4) | 0.0005 | 7 (58.3) | 33 (15.2) | 0.057 | 3 (21.4) | 34 (15.8) | 0.7 | 11 (78.5) | 29 (13.5) | 0.0002 |
| Abnormal pH | 1 (2.63) | 2 (1) | 0.4 | 1 (8.3) | 2 (0.9) | 0.1 | 0 (0) | 3 (1.4) | 1 | 0 (0) | 3 (1.4) | 1 |
| Asthenozoospermia | 16 (42) | 64 (33) | 0.5 | 2 (16.6) | 78 (36) | 0.5 | 6 (42.8) | 74 (34) | 0.6 | 7 (50) | 73 (34) | 0.44 |
| Oligozoospermia | 10 (26.3) | 52 (27) | 1 | 2 (16) | 60 (27.6) | 0.38 | 4 (28.5) | 58 (27) | 1 | 3 (21.4) | 59 (27.4) | 1 |
| Necrozoospermia | 21 (55) | 77 (40) | 0.3 | 4 (33) | 92 (42) | 0.4 | 8 (57.1) | 88 (41) | 0.5 | 9 (64.2) | 87 (40.4) | 0.34 |
| Teratozoospermia | 6 (15.8) | 28 (14.65) | 0.8 | 1 (6.2) | 33 (15.5) | 0.7 | 3 (21.4) | 31 (14) | 0.4 | 0 (0) | 34 (15.8) | 0.2 |
| Leukocytospermia | 2 (5.26) | 10 (5.23) | 1 | 1 (8.3) | 11 (5) | 0.5 | 0 (0) | 12 (5.6) | 1 | 2 (14.2) | 10 (4.65) | 0.2 |
| Hematospermia | 1 (2.63) | 3 (1.57) | 0.5 | 0 (0) | 4 (1.9) | 1 | 0 (0) | 4 (1.8) | 1 | 1 (7.14) | 3 (1.4) | 0.2 |
HPV: human papillomavirus; DNA: deoxyribonucleic acid; +: positive; −: negative; HR: high-risk; LR: low-risk; MI: multiple infection; presented data are not means; p values were obtained by Chi-square test; p values < 0.05 were considered statistically significant.